FDA Orange Book

Generic for Eskalith

Eskalith contains lithium carbonate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Eskalith is lithium carbonate. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 1 of the 2 Eskalith products the Orange Book lists.

Run it in Rivvi

Map Eskalith and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Eskalith products in the Orange Book

Eskalith products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
capsule, oral300MGDiscontinuedNone3AB
tablet, oral300MGDiscontinuedNone0None

NDA 016860, 017971, held by NOVEN THERAPEUTICS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic lithium carbonate

Approved generic versions of Eskalith
CompanyANDATE codeApprovedStrengths
ALEMBIC LTD079159AB (A-rated, therapeutically equivalent)January 12, 2009300MG
GLENMARK PHARMACEUTICALS LTD079139AB (A-rated, therapeutically equivalent)February 3, 2009300MG
HETERO LABS LTD UNIT III090702AB (A-rated, therapeutically equivalent)September 25, 2009300MG

Questions

Is there a generic for Eskalith?

Yes. The generic name for Eskalith is lithium carbonate. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 1 of the 2 Eskalith products the Orange Book lists.

What is the generic name for Eskalith?

The active ingredient in Eskalith is lithium carbonate, per the FDA Orange Book.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Eskalith and Lithium Carbonate

Try it on your own data today.

Free to start. Most teams are using it the same day.